Related Experiment Video
Updated: Jan 8, 2026

10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
5.2K
Precision Closure of Postsurgical Bronchopleural Fistulas Using Vascular Plugs
Gongmin Rim1, Deog Gon Cho2, Kwanyong Hyun2
1Department of Thoracic and Cardiovascular Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Annals of Thoracic Surgery Short Reports
|December 22, 2025
Summary
Amplatzer vascular plugs (AVPs) offer a safe and effective minimally invasive treatment for bronchopleural fistula (BPF). This approach shows promise as a first-line option for patients unable to undergo traditional surgery.
Area of Science:
- Thoracic Surgery
- Interventional Pulmonology
- Medical Devices
Background:
- Bronchopleural fistula (BPF) is a serious postoperative complication of thoracic surgery, associated with significant morbidity and mortality.
- Current surgical treatments for BPF are invasive, necessitating the exploration of less invasive alternatives.
- The Amplatzer vascular plug (AVP), a device primarily used for vascular embolization, presents a potential solution for BPF closure.
Purpose of the Study:
- To evaluate the efficacy and safety of using Amplatzer vascular plugs (AVPs) for bronchoscopic closure of bronchopleural fistulas (BPFs).
Main Methods:
- The study involved 3 male patients who underwent bronchoscopic closure of BPFs using AVPs II and IV after lobectomy or pneumonectomy.
- AVP II was utilized for fistulas larger than 6 mm, while AVP IV was used for fistulas smaller than 6 mm.
- Procedures were conducted under general anesthesia in a hybrid operating room, employing flexible bronchoscopy with fluoroscopic guidance.
Main Results:
- Successful closure of bronchopleural fistulas was achieved in all three patients.
- No complications were reported during or after the procedures.
- Follow-up over 11 months (range 3-22 months) demonstrated stable device placement, clinical improvement, and no 90-day mortality.
Conclusions:
- Amplatzer vascular plug (AVP) closure represents a safe, effective, and minimally invasive method for managing bronchopleural fistulas (BPFs).
- This technique is a promising first-line treatment option for patients with BPF who are not candidates for conventional surgery.
- Further research is warranted to confirm these preliminary findings and establish AVP closure as a standard treatment modality.
Related Concept Videos
Flail Chest-II
488
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
488
Tracheostomy: Procedure and Tubes
2.7K
A tracheostomy is a surgical procedure that creates an artificial opening into the trachea, typically at the second or third cartilaginous ring level. This opening allows the insertion of a tracheostomy tube, which can replace an endotracheal tube, provide mechanical ventilation, bypass an upper airway obstruction, or remove accumulated tracheobronchial secretions.
Tracheostomy tubes can be made of semiflexible plastic (polyurethane or silicone), rigid plastic, or metal, and they come in...
Tracheostomy tubes can be made of semiflexible plastic (polyurethane or silicone), rigid plastic, or metal, and they come in...
2.7K
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852

